Volume | 12,501 |
|
|||||
News | - | ||||||
Day High | 0.82 | Low High |
|||||
Day Low | 0.72 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Qilian International Holding Group Ltd | QLI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.82 | 0.72 | 0.82 | 0.7486 | 0.789 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
90 | 12,501 | US$ 0.7566748 | US$ 9,459 | - | 0.3551 - 1.2974 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:52:22 | formt | 200 | US$ 0.6842 | USD |
Qilian International Holding Group Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
26.81M | 35.75M | - | 46.47M | -7.78M | -0.22 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Qilian News
Date | Time | Source | News Article |
---|---|---|---|
3/11/2024 | 05:02 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2/15/2024 | 15:27 | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private.. |
2/01/2024 | 15:15 | Edgar (US Regulatory) | Form NT 20-F - Notification of inability to timely file Form.. |
1/12/2024 | 06:30 | PR Newswire (US) | Qilian International Holding Group Receives 180-day.. |
12/07/2023 | 05:02 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10/31/2023 | 15:05 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
8/04/2023 | 15:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
7/25/2023 | 15:05 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
7/17/2023 | 09:30 | PR Newswire (US) | Qilian International Holding Group Ltd Receives Nasdaq.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QLI Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.7482 | 0.82005 | 0.6421 | 0.7689578 | 12,095 | -0.064 | -8.55% |
1 Month | 0.7462 | 0.964 | 0.5501 | 0.7242165 | 300,962 | -0.062 | -8.31% |
3 Months | 0.6336 | 0.964 | 0.3551 | 0.6919111 | 174,681 | 0.0506 | 7.99% |
6 Months | 0.5962 | 0.964 | 0.3551 | 0.6823521 | 91,710 | 0.088 | 14.76% |
1 Year | 1.18 | 1.2974 | 0.3551 | 0.6870458 | 46,752 | -0.4958 | -42.02% |
3 Years | 4.35 | 4.99 | 0.3551 | 1.84 | 28,318 | -3.67 | -84.27% |
5 Years | 8.01 | 22.00 | 0.3551 | 6.41 | 74,770 | -7.33 | -91.46% |
Qilian Description
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generate most of the revenue. |